Product description
| Symbol | Cusip | Name | Amount | Value | Title Of Class | Pay of profile | |
|---|---|---|---|---|---|---|---|
| 00847X104 | 00847X104 | Agios Pharmaceuticals Inc | 9438.0 | 209806.74 | CORP | Long | |
| 23954D109 | 23954D109 | Day One Biopharmaceuticals Inc | 12540.0 | 145213.2 | CORP | Long | |
| 452327109 | 452327109 | Illumina Inc | 4623.0 | 471314.85 | CORP | Long | |
| 52490G102 | 52490G102 | Legend Biotech Corp | 4700.0 | 285854.0 | CORP | Long | |
| N/A | N/A | MorphoSys AG | 2332.0 | 61834.68 | CORP | Long | |
| 75886F107 | 75886F107 | Regeneron Pharmaceuticals Inc | 990.0 | 815571.9 | CORP | Long | |
| 24344T101 | 24344T101 | Deciphera Pharmaceuticals Inc | 18085.0 | 228051.85 | CORP | Long | |
| 31846V328 | 31846V328 | First American Treasury Obliga | 211739.87 | 211739.87 | RF | Long | |
| 375558103 | 375558103 | Gilead Sciences Inc | 6608.0 | 506172.8 | CORP | Long | |
| 589492107 | 589492107 | Mereo Biopharma Group PLC | 192329.0 | 401967.61 | CORP | Long | |
| 60468T105 | 60468T105 | Mirati Therapeutics Inc | 3774.0 | 214174.5 | CORP | Long | |
| N/A | N/A | Merus NV | 7194.0 | 177979.56 | CORP | Long | |
| 45253H101 | 45253H101 | ImmunoGen Inc | 25682.0 | 753766.7 | CORP | Long | |
| 88025U109 | 88025U109 | 10X Genomics Inc | 6270.0 | 272870.4 | CORP | Long | |
| 03969F109 | 03969F109 | Arcus Biosciences Inc | 9108.0 | 137166.48 | CORP | Long | |
| 04335A105 | 04335A105 | Arvinas Inc | 6864.0 | 150802.08 | CORP | Long | |
| 07725L102 | 07725L102 | BeiGene Ltd | 2442.0 | 456507.48 | CORP | Long | |
| 110122108 | 110122108 | Bristol-Myers Squibb Co | 7463.0 | 368522.94 | CORP | Long | |
| 230031106 | 230031106 | Cullinan Oncology Inc | 15906.0 | 130270.14 | CORP | Long | |
| 30063P105 | 30063P105 | Exact Sciences Corp | 4356.0 | 278784.0 | CORP | Long | |
| 45337C102 | 45337C102 | Incyte Corp | 7524.0 | 408854.16 | CORP | Long | |
| 516544103 | 516544103 | Lantheus Holdings Inc | 3564.0 | 255253.68 | CORP | Long | |
| 58933Y105 | 58933Y105 | Merck & Co Inc | 6996.0 | 716950.08 | CORP | Long | |
| N/A | N/A | Chugai Pharmaceutical Co Ltd | 13926.0 | 490124.56 | CORP | Long | |
| 76155X100 | 76155X100 | REVOLUTION Medicines Inc | 9250.0 | 215802.5 | CORP | Long | |
| 98943L107 | 98943L107 | Zentalis Pharmaceuticals Inc | 5235.0 | 58893.75 | CORP | Long | |
| N/A | N/A | Daiichi Sankyo Co Ltd | 21912.0 | 591177.66 | CORP | Long | |
| N/A | N/A | Siemens Healthineers AG | 6090.0 | 350935.67 | CORP | Long | |
| N/A | N/A | CureVac NV | 14787.0 | 79849.8 | CORP | Long | |
| 03940C100 | 03940C100 | Arcellx Inc | 3708.0 | 194781.24 | CORP | Long | |
| 30161Q104 | 30161Q104 | Exelixis Inc | 17959.0 | 391685.79 | CORP | Long | |
| 45258D105 | 45258D105 | Immunocore Holdings PLC | 3828.0 | 201850.44 | CORP | Long | |
| 45826J105 | 45826J105 | Intellia Therapeutics Inc | 16368.0 | 484983.84 | CORP | Long | |
| 60770K107 | 60770K107 | Moderna Inc | 3252.0 | 252680.4 | CORP | Long | |
| 15117B202 | 15117B202 | Celldex Therapeutics Inc | 11560.0 | 349227.6 | CORP | Long | |
| N/A | N/A | AstraZeneca PLC | 4620.0 | 590601.31 | CORP | Long | |
| 372303206 | 372303206 | Genmab A/S | 11946.0 | 377613.06 | CORP | Long | |
| 80810D103 | 80810D103 | Schrodinger Inc/United States | 11635.0 | 361732.15 | CORP | Long | |
| 40131M109 | 40131M109 | Guardant Health Inc | 15856.0 | 399095.52 | CORP | Long | |
| 68404L201 | 68404L201 | Option Care Health Inc | 7659.0 | 227855.25 | CORP | Long | |
| N/A | N/A | Novartis AG | 6488.0 | 630648.12 | CORP | Long | |
| 75943R102 | 75943R102 | Relay Therapeutics Inc | 22110.0 | 174890.1 | CORP | Long | |
| N/A | N/A | CRISPR Therapeutics AG | 7266.0 | 484860.18 | CORP | Long | |
| 04016X101 | 04016X101 | Argenx SE | 1206.0 | 543435.66 | CORP | Long | |
| 19240Q201 | 19240Q201 | Cogent Biosciences Inc | 12936.0 | 99219.12 | CORP | Long | |
| 36118A100 | 36118A100 | Fusion Pharmaceuticals Inc | 54978.0 | 304578.12 | CORP | Long | |
| 09627Y109 | 09627Y109 | Blueprint Medicines Corp | 4312.0 | 300287.68 | CORP | Long |